Washington: The US Food and Drug Administration on Wednesday announced
the approval of Trumenba, the first vaccine licensed in the United
States to prevent invasive meningococcal disease caused by Neisseria
meningitidis serogroup B in individuals 10 through 25 years of age.READ MORE... http://www.indiamedicaltimes.com/2014/10/30/us-fda-approves-vaccine-to-prevent-serogroup-b-meningococcal-disease/
Oct 29, 2014
WHO welcomes Swissmedic approval of Ebola vaccine trial at Lausanne University Hospital
GENEVA: 28 October 2014: The World Health Organization (WHO) welcomes the approval by Swissmedic, the Swiss regulatory authority for therapeutic products, for a trial with an experimental Ebola vaccine at the Lausanne University Hospital (CHUV). This marks the latest step towards bringing safe and effective Ebola vaccines for testing and implementation as quickly as possible.
Oct 28, 2014
Implication of the Seoul declaration on public health of India
http://www.ijph.in/article.asp?issn=0019-557X;year=2014;volume=58;issue=3;spage=143;epage=146;aulast=Kishore
Observing epidemiological transition of various diseases throughout the world, it is quite apparent that the burden of noncommunicable diseases (NCDs) is a major concern. In this era of globalization, developing countries, including India cannot remain untouched from the threats and major developments in the field of international health and NCDs.
Observing epidemiological transition of various diseases throughout the world, it is quite apparent that the burden of noncommunicable diseases (NCDs) is a major concern. In this era of globalization, developing countries, including India cannot remain untouched from the threats and major developments in the field of international health and NCDs.
Subscribe to:
Posts (Atom)